why choose us

First received: February 27, 2023

Clinical Trial: Radiofrequency Ablation in TIR3A Nodules With Negative Genetic Evaluation

Study Status: Completed

Recruit Status: RECRUITING

Condition: Thyroid Nodule

Study Type: INTERVENTIONAL


Official Title: Radiofrequency Ablation for Treating Thyroid Nodules Classified as TIR3A, With a Negative Genetic Evaluation for Thyroid Carcinoma

Brief Summary: The goal of this clinical trial is to demonstrate that TIR3A nodules with negative genetic test can be safely and effectively treated by radiofrequency ablation, with nodular shrinkage and improvement of clinical symptoms.Fine needle aspiration cytology is the gold standard test for differential diagnosis of thyroid nodules, but sometimes the result can be indeterminate with a risk of malignancy of 10-30%.In these cases the ablation is not indicated and many patients with benign nodules that may benefit from the…

Read more